Literature DB >> 836010

Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

D A Spyker, R J Rugloski, R L Vann, W M O'Brien.   

Abstract

Amoxicillin was studied in normal subjects after intravenous, oral, and intramuscular administration of 250-, 500-, and 1,000-mg doses. Serum drug levels were analyzed using a two-compartment open model, as well as area under the curve (AUC) and urinary recovery. The variations of these pharmacokinetic parameters were then examined using the three-way analysis of variance and linear regression equations. These results confirmed nearly complete oral absorption: AUC was 93% of intravenous absorption, and urinary recovery was 86%. The intramuscular administration of amoxicillin results in complete and reliable absorption with peak drug levels, AUCs, and urinary recovery equivalent to oral dosage. The absorption of lyophilized amoxicillin after intramuscular injection resulted in an AUC that was 92% of intravenous absorption and urinary recovery of 91%. The peak serum levels, time to peak, and other pharmacokinetic parameters for intramuscular injection were nearly identical to those for oral administration. Kinetics of both intramuscular and oral administration exhibited dose-dependent absorption (absorption rate constant, 1.3/h for 250 mg and 0.7/h for 1,000 mg). This resulted in relatively later and lower peak serum levels for increasing dose. Total absorption, however, showed no dose dependence, as indicated by urinary recovery and AUC, which changed by less than 10%.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 836010      PMCID: PMC351932          DOI: 10.1128/AAC.11.1.132

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

Review 1.  Clinical pharmacokinetics (second of two parts).

Authors:  D J Greenblatt; J Koch-Weser
Journal:  N Engl J Med       Date:  1975-11-06       Impact factor: 91.245

2.  Drug therapy. Clinical Pharmacokinetics (first of two parts).

Authors:  D J Greenblatt; J Kock-Weser
Journal:  N Engl J Med       Date:  1975-10-02       Impact factor: 91.245

3.  KINETIC ANALYSIS OF BLOOD LEVELS AND URINARY EXCRETION IN THE ABSORPTIVE PHASE AFTER SINGLE DOSES OF DRUG.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1964-11       Impact factor: 3.534

4.  Pharmacological studies of 6 (D(-) -amino-p-hydroxyphenylacetamido) penicillanic acid in humans.

Authors:  H C Neu; E B Winshell
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970

5.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

6.  Generalized solution to linear, to-compartment, open model for drug distribution.

Authors:  K B Bischoff; R L Dedrick
Journal:  J Theor Biol       Date:  1970-10       Impact factor: 2.691

7.  Sequence effect on ampicillin blood levels noted in an amoxicillin, ampicillin, and epicillin triple crossover study.

Authors:  A Philipson; L D Sabath; B Rosner
Journal:  Antimicrob Agents Chemother       Date:  1975-09       Impact factor: 5.191

Review 8.  Drug therapy. Benzodiazepines (first of two parts).

Authors:  D J Greenblatt; R I Shader
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

9.  Amoxycillin: a new semi-synthetic penicillin.

Authors:  R Sutherland; E A Croydon; G N Rolinson
Journal:  Br Med J       Date:  1972-07-01

10.  Amoxicillin, a new penicillin antibiotic.

Authors:  H H Handsfield; H Clark; J F Wallace; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191

View more
  37 in total

Review 1.  New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review.

Authors:  Amparo Sánchez Navarro
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Variations in amoxicillin pharmacokinetic/pharmacodynamic parameters may explain treatment failures in acute otitis media.

Authors:  Michael E Pichichero; Michael D Reed
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

3.  Enzymatic method for rapid and sensitive determination of beta-lactam antibiotics.

Authors:  J M Frère; D Klein; J M Ghuysen
Journal:  Antimicrob Agents Chemother       Date:  1980-10       Impact factor: 5.191

4.  Low bioavailability of amoxicillin in rats as a consequence of presystemic degradation in the intestine.

Authors:  J Chesa-Jiménez; J E Peris; F Torres-Molina; L Granero
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 5.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  A comparison of the pharmacokinetics of bacampicillin, ampicillin, amoxicillin, and cyclacillin: oral administration in infants and children.

Authors:  G M McCracken
Journal:  Bull N Y Acad Med       Date:  1983-06

7.  Predicting fraction dose absorbed in humans using a macroscopic mass balance approach.

Authors:  P J Sinko; G D Leesman; G L Amidon
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

8.  Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation.

Authors:  Mariana Gil Escalante; Tim D Eubank; Binnaz Leblebicioglu; John D Walters
Journal:  J Periodontol       Date:  2015-08-07       Impact factor: 6.993

9.  Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.

Authors:  D A Spyker; B L Thomas; M A Sande; W K Bolton
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

10.  Human pharmacokinetics and disposition of sarmoxicillin, a lipophilic amoxicillin prodrug.

Authors:  R D Smyth; M Pfeffer; D R Van Harken; A Cohen; G H Hottendorf
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.